AntiCov-220 (041434)

AntiCov-220 is a multi-component herbal and nutritional composition developed by Dr. Nguyen Thi Trieu for the prevention and treatment of COVID-19. The formulation consists of fractional extracts from several herbs, including *Adenosma glutinosum*, *Eclipta prostrata*, *Phyllanthus urinaria*, *Impatiens balsamina*, and *Allium sativum*, combined with vitamins (Ascorbic Acid, Pyridoxine 5-phosphate, Cyanocobalamin), L-arginine, rutin, and pregnenolone acetate. It is designed to target SARS-CoV-2 by neutralizing the viral spike protein and inhibiting viral replication. Additionally, AntiCov-220 aims to modulate the body's inflammatory response by stabilizing blood cortisol levels and reducing inflammatory markers such as C-reactive protein (CRP) and Cyfra 21-1. The composition is also intended to prevent thrombotic complications and support the restoration of cellular physiological function following infection.